• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为拓扑异构酶I抑制剂的特苯并咪唑类化合物的合成与评价

Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors.

作者信息

Sun Q, Gatto B, Yu C, Liu A, Liu L F, LaVoie E J

机构信息

Department of Pharmaceutical Chemistry, Rutgers, State University of New Jersey, Piscataway 08855, USA.

出版信息

J Med Chem. 1995 Sep 1;38(18):3638-44. doi: 10.1021/jm00018a024.

DOI:10.1021/jm00018a024
PMID:7658451
Abstract

The synthesis and pharmacological activity of a series of terbenzimidazoles are described. The ability of these derivatives to induce DNA cleavage in the presence of topoisomerase I was evaluated in vitro. These analogs were also assayed for their cytotoxicity in RPMI 8402 cells and the camptothecin-resistant CPT-K5 cells. In addition the potential for these compounds to serve as substrates for MDR1 was also determined. Several terbenzimidazoles exhibited similar cytotoxicity against variants of human tumor cells that either overexpress MDR1 or are camptothecin-resistant.

摘要

描述了一系列叔苯并咪唑的合成及药理活性。在体外评估了这些衍生物在拓扑异构酶I存在下诱导DNA裂解的能力。还测定了这些类似物在RPMI 8402细胞和喜树碱耐药的CPT-K5细胞中的细胞毒性。此外,还确定了这些化合物作为MDR1底物的可能性。几种叔苯并咪唑对过表达MDR1或对喜树碱耐药的人类肿瘤细胞变体表现出相似的细胞毒性。

相似文献

1
Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors.作为拓扑异构酶I抑制剂的特苯并咪唑类化合物的合成与评价
J Med Chem. 1995 Sep 1;38(18):3638-44. doi: 10.1021/jm00018a024.
2
Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor agents.5-取代的特苯并咪唑作为拓扑异构酶I抑制剂和抗肿瘤剂的定量构效关系
Bioorg Med Chem. 1998 Feb;6(2):163-72. doi: 10.1016/s0968-0896(97)10021-9.
3
Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase I.关于抑制拓扑异构酶I的联苯并咪唑和特苯并咪唑的比较定量构效关系研究。
Bioorg Med Chem. 2001 Nov;9(11):2885-93. doi: 10.1016/s0968-0896(01)00174-2.
4
Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.新型拓扑异构酶 I 抑制剂的合成及生物活性:2-芳基取代的 2-双-1H-苯并咪唑。
Eur J Med Chem. 2011 Feb;46(2):659-69. doi: 10.1016/j.ejmech.2010.11.046. Epub 2010 Dec 8.
5
Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons.作为拓扑异构酶I抑制剂的苯并咪唑及相关杂环化合物的构效关系
Bioorg Med Chem. 1996 Apr;4(4):621-30. doi: 10.1016/0968-0896(96)00047-8.
6
2"-Substituted 5-phenylterbenzimidazoles as topoisomerase I poisons.作为拓扑异构酶I抑制剂的2''-取代5-苯基三联苯并咪唑类化合物。
Bioorg Med Chem. 2000 Jun;8(6):1371-82. doi: 10.1016/s0968-0896(00)00054-7.
7
Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles.5-溴-和5-苯基三联苯并咪唑对拓扑异构酶I的抑制作用及细胞毒性
Bioorg Med Chem. 2000 Nov;8(11):2591-600. doi: 10.1016/s0968-0896(00)00188-7.
8
Terbenzimidazoles: influence of 2"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.苯并咪唑类:2''-、4-和5-取代基对细胞毒性及作为拓扑异构酶I抑制剂的相对效力的影响。
J Med Chem. 1997 Aug 29;40(18):2818-24. doi: 10.1021/jm960658g.
9
Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons.珊瑚灵及相关化合物作为哺乳动物拓扑异构酶I和拓扑异构酶II的抑制剂
Bioorg Med Chem. 1996 Jun;4(6):781-91. doi: 10.1016/0968-0896(96)00054-5.
10
A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures.一种新型哺乳动物DNA拓扑异构酶I抑制剂Hoechst 33342:对人细胞培养物的细胞毒性和耐药性
Cancer Res. 1993 Mar 15;53(6):1332-7.

引用本文的文献

1
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-(ω-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines.1-(喹啉-1-基甲基)-和 1-(ω-叔氨基)烷基取代的 2-苯基、2-苄基和 2-[(苯并三唑-1/2-基)甲基]苯并咪唑类化合物对人癌细胞系的初步抗增殖活性评价。
Mol Divers. 2013 Aug;17(3):409-19. doi: 10.1007/s11030-013-9440-3. Epub 2013 Apr 13.
2
3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.3,4-二甲氧基苯基双苯并咪唑,一种新型的 DNA 拓扑异构酶抑制剂,优先靶向大肠埃希菌拓扑异构酶 I。
J Antimicrob Chemother. 2012 Dec;67(12):2882-91. doi: 10.1093/jac/dks322. Epub 2012 Sep 3.
3
Preparation of Tyrian purple (6,6'-dibromoindigo): past and present.泰尔紫(6,6'-二溴靛蓝)的制备:过去与现在。
Molecules. 2010 Aug 10;15(8):5473-508. doi: 10.3390/molecules15085473.
4
Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site.双苯并咪唑与远端位点的小沟定向结合诱导拓扑异构酶I介导的DNA切割。
J Mol Biol. 2007 Jan 19;365(3):561-9. doi: 10.1016/j.jmb.2006.10.032. Epub 2006 Oct 13.
5
Molecular characterization of recombinant Pneumocystis carinii topoisomerase I: differential interactions with human topoisomerase I poisons and pentamidine.重组卡氏肺孢子虫拓扑异构酶I的分子特征:与人类拓扑异构酶I毒素及喷他脒的差异相互作用
Antimicrob Agents Chemother. 2002 Jul;46(7):2145-54. doi: 10.1128/AAC.46.7.2145-2154.2002.
6
A terbenzimidazole that preferentially binds and conformationally alters structurally distinct DNA duplex domains: a potential mechanism for topoisomerase I poisoning.一种优先结合并在构象上改变结构不同的DNA双链结构域的苯并咪唑:一种拓扑异构酶I中毒的潜在机制。
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13565-70. doi: 10.1073/pnas.94.25.13565.